Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02155465 |
Title | Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Memorial Sloan-Kettering Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Memoral Sloan Kettering Cancer Center | Basking Ridge | New Jersey | United States | Details | ||
Memorial Sloan Kettering Cancer Center @ Suffolk | Commack | New York | 11725 | United States | Details | |
Memorial Sloan Kettering West Harrison | Harrison | New York | 10604 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Memorial Sloan Kettering at Mercy Medical Center | Rockville Centre | New York | United States | Details | ||
Memoral Sloan Kettering Cancer Center at Phelps | Sleepy Hollow | New York | 10591 | United States | Details |